| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 26-Dec-08 | | Total Revenue | 1,216,379 | 1,308,801 | 1,264,523 | 1,639,189 | | Cost of Revenue | 1,022,542 | 1,088,842 | 1,101,771 | 1,435,990 | | | Gross Profit | 193,837 | 219,959 | 162,752 | 203,199 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 72,095 | 62,316 | 69,248 | 65,112 | | Non Recurring |
-
|
-
|
-
|
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 121,742 | 157,643 | 93,504 | 138,087 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 956 | 6,757 | (5,165) | (39,053) | | Earnings Before Interest And Taxes | 122,698 | 156,197 | 96,542 | 93,644 | | Interest Expense | 4,648 | 1,302 | 4,167 | 1,417 | | Income Before Tax | 118,050 | 154,895 | 92,375 | 92,227 | | Income Tax Expense | 22,061 | 27,561 | 18,003 | (7,655) | | Minority Interest | (12,630) |
-
|
-
| (5,390) | | | | Net Income From Continuing Ops | 83,359 | 127,334 | 74,372 | 99,882 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 83,359 | 127,334 | 74,372 | 99,882 | | Preferred Stock And Other Adjustments |
-
| 1,509 | (1,509) |
-
| | | Net Income Applicable To Common Shares | $83,359 | $128,843 | $72,863 | $99,882 |
|
1.48% Nasdaq 
Income Statement
